GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its rivals? We will compare GE HealthCare Technologies to similar companies based on the strength of its dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.
Valuation and Earnings
This table compares GE HealthCare Technologies and its rivals gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| GE HealthCare Technologies | $20.62 billion | $2.08 billion | 17.51 |
| GE HealthCare Technologies Competitors | $1.89 billion | $136.85 million | 5.95 |
GE HealthCare Technologies has higher revenue and earnings than its rivals. GE HealthCare Technologies is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| GE HealthCare Technologies | 0 | 11 | 12 | 0 | 2.52 |
| GE HealthCare Technologies Competitors | 4302 | 10596 | 18377 | 837 | 2.46 |
GE HealthCare Technologies presently has a consensus target price of $82.17, suggesting a potential downside of 1.02%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.54%. Given GE HealthCare Technologies’ rivals higher probable upside, analysts plainly believe GE HealthCare Technologies has less favorable growth aspects than its rivals.
Volatility and Risk
GE HealthCare Technologies has a beta of 0.65, meaning that its share price is 35% less volatile than the S&P 500. Comparatively, GE HealthCare Technologies’ rivals have a beta of 5.41, meaning that their average share price is 441% more volatile than the S&P 500.
Dividends
GE HealthCare Technologies pays an annual dividend of $0.16 per share and has a dividend yield of 0.2%. GE HealthCare Technologies pays out 3.4% of its earnings in the form of a dividend. As a group, “Healthcare Equipment & Supplies” companies pay a dividend yield of 2.2% and pay out 42.0% of their earnings in the form of a dividend. GE HealthCare Technologies has raised its dividend for 1 consecutive years.
Profitability
This table compares GE HealthCare Technologies and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| GE HealthCare Technologies | 9.96% | 20.45% | 5.97% |
| GE HealthCare Technologies Competitors | -300.62% | -179.55% | -22.71% |
Insider & Institutional Ownership
82.1% of GE HealthCare Technologies shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 0.4% of GE HealthCare Technologies shares are owned by company insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Summary
GE HealthCare Technologies beats its rivals on 9 of the 15 factors compared.
About GE HealthCare Technologies
GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
